NCT02693613View on ClinicalTrials.gov

Pharmacokinetic Study of ASP1517 With Kremezin®

PHASE1CompletedINTERVENTIONAL

Enrollment

34

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

ASP1517

Oral

DRUG

Kremezin®

Oral

Trial Locations (1)

Unknown

Site JP00001, Tokyo

Sponsors

Lead Sponsor

Astellas Pharma Inc

Collaborators (1)

All Listed Sponsors

collaborator

FibroGen

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY

NCT02693613 - Pharmacokinetic Study of ASP1517 With Kremezin® | Biotech Hunter | Biotech Hunter